A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors

Trial Profile

A Phase II Trial of Rebeccamycin Analogue (NSC #655649) in Children With Solid Tumors

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Feb 2013

At a glance

  • Drugs Becatecarin (Primary)
  • Indications Non-Hodgkin's lymphoma; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2006 Status change
    • 11 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top